Disease

Endometrial Neoplasms

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 1 TRIAL

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

ClinicalTrials.gov

This is a Phase 1/1b/2 early-stage trial registration with no posted results; it describes planned enrollment and primary endpoints only, reflecting hypothesis-generating and dose-finding work typical of first-in-human oncology studies.

PreliminaryEli Lilly and Company Itraconazole Ovarian Neoplasms

Reported

Planned enrollment575

Study phasePhase 1a/1b/2

Phase 1a primary outcomeRecommended phase 2 dose (RP2D) of Sofe-M a…

JUL 24, 2026 · JOURNAL ARTICLE

Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.

Journal of Obstetrics and Gynaecology

Small prospective observational study comparing three weight-management approaches in endometrial cancer patients, with no randomization and limited sample size limiting causal inference.

PreliminaryHui Zeng Yuxuan Wei Zhaohui Zhong

Reported

Sample size53

Sleeve gastrectomy arm10

Semaglutide arm23